FDA.reportPublic FDA data

OHM PANCREATIC TERRAIN

Manufacturer
OHM PHARMA INC.
Effective date
2021-01-11
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 22:57:23

Label at a glance#

ProductOHM PANCREATIC TERRAIN
Active ingredientACTIVATED CHARCOAL, CEANOTHUS AMERICANUS LEAF, GALIUM APARINE, VERONICASTRUM VIRGINICUM ROOT, MANDRAGORA OFFICINARUM ROOT, MOMORDICA BALSAMINA IMMATURE FRUIT, QUASSIA AMARA WOOD
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENTS (HPUS*): Equal amounts of: Carbo Vegetabilis 12X, Ceanothus Americanus 10X, Galium Aparine 5X, Leptandra Virginica 5X, Mandragora Officinarum 10X, Momordica Balsamina 8X, Quassia Amara 5X.

OTC - ACTIVE INGREDIENT SECTION

*The letters "HPUS" indicate the components in this product are officially monographed in the Homeopathic Pharmacopeia of the United States.

INDICATIONS & USAGE SECTION

USES: Temporarily relieves functional ailments of the endocrine/exocrine pancreas.**

SPL UNCLASSIFIED SECTION

**This statement has not been evaluated by the FDA.
It is based on documented Homeopathic Materia Medica.

WARNINGS SECTION

WARNINGS:

IF PREGNANT OR BREAST-FEEDING, ask a health professional before use. If symptoms worsen or persist for more than 5 days, discontinue use and contact a health care professional.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF THE REACH OF CHILDREN.

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS: To open ampoule snap top up and away from you. Using pipette place entire content under the tongue, hold it for 30 seconds and swallow.

POSOLOGY: Adults and children over 12 years: In acute conditions: 1 ampoule every 12 hours. In chronic conditions: 1 ampoule one to four times per week, or as directed by a health professional.

Children under 12 years use 1/2 the adult dose.

Discard unused solution. Solution does not contain any preservatives.

Not for injection.

OTHER SAFETY INFORMATION

OTHER INFORMATION: Store at controlled room temperature. Tamper evident seal. Do not use if box seal is missing or broken.

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS: Isotonic sodium chloride solution.

OTC - QUESTIONS SECTION

Mfg. By: OHM PHARMA, INC. / Mineral Wells, TX 76067

Made in USA

www.ohmpharma.com

OTC - PURPOSE SECTION

Functional ailments of the endrocrine/exocrine pancreas relief

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC: 66096-182-06

OHM PANCREATIC TERRAIN

HOMEOPATHIC MEDICINE

Pharmaceutical Grade. Professional use only.

CONTENTS: 12 oral ampoules of 2.2 ml each.

Terrain Box Label EnglishTerrain Box Label English

Terrain Box Label SpanishTerrain Box Label Spanish

Ampoule LabelAmpoule Label

Insert EnglishInsert English

Insert SpanishInsert Spanish

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
66096-18266096-182-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
NameUNIIKind
SODIUM CHLORIDE451W47IQ8XIACT
ACTIVATED CHARCOAL2P3VWU3H10ACTIB
CEANOTHUS AMERICANUS LEAF25B1Y14T8NACTIB
GALIUM APARINEZ4B6561488ACTIB
VERONICASTRUM VIRGINICUM ROOTM2O62YTN42ACTIB
MANDRAGORA OFFICINARUM ROOTI2XCB174VBACTIB
MOMORDICA BALSAMINA IMMATURE FRUITWUW1665V10ACTIB
QUASSIA AMARA WOODS5249Q85HWACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
00a6b4bb-4b0e-429b-a10d-e4af549c4fd8f46a451b-e5f8-4ee3-865e-f43be5021c0b2022-01-04WarningsExact identifier
spl set id: f46a451b-e5f8-4ee3-865e-f43be5021c0b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.